Just like the Multi-Tool Pen, BRT does more than check the boxes. From pre-clinical support to in vitro and in vivo models, we deliver custom immunotoxicology solutions built to meet your study’s exact requirements.
Looking for quick reference materials? View our one-pager or learn about our service-specific capabilities below.
Comprehensive models supporting immune safety evaluation across study types.
Human cell–based assays providing mechanistic insight into immunotoxicology.
Disease and hypersensitivity models to evaluate host resistance and immune response.
Meet with Dr. Florence Burleson — Co-Founder & EVP of BRT
With 30+ years of experience in immunotoxicology/immuno-safety and GLP study direction, Dr. Burleson brings unmatched depth to every study. She has led functional, host-resistance, and immunotoxicology programs across government, pharmaceutical, and CRO environments.
Meet our team in person at Booth #915 during the 46th Annual Meeting of the American College of Toxicology, November 17–18.
